Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population:: a retrospective analysis of case records

被引:44
作者
Osman, A. [1 ]
Enstrom, C.
Arbring, K.
Soderkvist, P.
Lindahl, T. L.
机构
[1] Linkoping Univ Hosp, Dept Clin Chem, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Emergency Med, S-58185 Linkoping, Sweden
[3] Linkoping Univ, Dept Biomed & Surg, Div Cell Biol, Linkoping, Sweden
关键词
INR; VKORC1; warfarin;
D O I
10.1111/j.1538-7836.2006.02039.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Vitamin K epoxide reductase (VKORC1) is the site of inhibition by coumarins. Several reports have shown that mutations in the gene encoding VKORC1 affect the sensitivity of the enzyme for warfarin. Recently, three main haplotypes of VKORC1; *2, *3 and *4 have been observed, that explain most of the genetic variability in warfarin dose among Caucasians. Objectives: We have investigated the main haplotypes of the VKORC1 gene in a Swedish population. Additional objective was to screen the studied population for mutations in the coding region of VKORC1 gene. Patients/methods: Warfarin doses and plasma S- and R-warfarin of 98 patients [with a target International Normalized Ratio (INR) of 2.0-3.0] have been correlated to VKORC1 haplotypes. Controls of 180 healthy individuals have also been haplotyped. Furthermore, a retrospective analysis of case records was performed to find any evidence indicating influence of VKORC1 haplotypes on warfarin response in the first 4 weeks (initiation phase) and the latest 12 months of warfarin treatment. Results and conclusions: Our result shows that VKORC1*2 is the most important haplotype for warfarin dosage. Patients with VKORC1*2 haplotype had more frequent visits than patients with VKORC1*3 or *4 haplotypes, higher coefficient of variation (CV) of prothrombin time-INR and higher percentage of INR values outside the therapeutic interval (i.e. 2.0-3.0) than patients with VKORC1*3 or *4 haplotypes. Also, there was a statistically significant difference in warfarin dose (P < 0.001) and R-warfarin plasma levels (P < 0.01) between VKORC1*2 and VKORC1*3 or 4 haplotypes. Patients with VKORC1*2 haplotype seem to require much lower warfarin doses than other patients.
引用
收藏
页码:1723 / 1729
页数:7
相关论文
共 35 条
  • [1] CASE OF APPARENT RESISTANCE OF RATTUS-NORVEGICUS BERKENHOUT TO ANTICOAGULANT POISONS
    BOYLE, CM
    [J]. NATURE, 1960, 188 (4749) : 517 - 517
  • [2] FACTORS AFFECTING THE PRECISION OF WARFARIN TREATMENT
    BRITT, RP
    JAMES, AH
    RASKINO, CL
    THOMPSON, SG
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (11) : 1003 - 1006
  • [3] CAMBELL HA, 1941, J BIOL CHEM, V138, P21
  • [4] COLVIN BT, 1990, J CLIN PATHOL, V43, P177
  • [5] A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
    D'Andrea, G
    D'Ambrosio, RL
    Di Perna, P
    Chetta, M
    Santacroce, R
    Brancaccio, V
    Grandone, E
    Margaglione, M
    [J]. BLOOD, 2005, 105 (02) : 645 - 649
  • [6] WARFARIN INHIBITION OF VITAMIN-K 2,3-EPOXIDE REDUCTASE IN RAT-LIVER MICROSOMES
    FASCO, MJ
    PRINCIPE, LM
    WALSH, WA
    FRIEDMAN, PA
    [J]. BIOCHEMISTRY, 1983, 22 (24) : 5655 - 5660
  • [7] VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation
    Geisen, C
    Watzka, M
    Sittinger, K
    Steffens, M
    Daugela, L
    Seifried, E
    Müller, CR
    Wienker, TF
    Oldenburg, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) : 773 - 779
  • [8] Interaction of warfarin with drugs, natural substances, and foods
    Greenblatt, DJ
    von Moltke, LL
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (02) : 127 - 132
  • [9] Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit I
    Harrington, DJ
    Underwood, S
    Morse, C
    Shearer, MJ
    Tuddenham, EGD
    Mumford, AD
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 93 (01) : 23 - 26
  • [10] Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation - A three-year follow-up from the Swedish national external quality assessment scheme
    Hillarp, A
    Egberg, N
    Nordin, G
    Stigendal, L
    Fagerberg, I
    Lindahl, TL
    [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) : 300 - 307